These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 17305567)
1. COX-2 inhibitors celecoxib and parecoxib: valuable options for postoperative pain management. Gajraj NM Curr Top Med Chem; 2007; 7(3):235-49. PubMed ID: 17305567 [TBL] [Abstract][Full Text] [Related]
2. [Selective inhibitors of cyclooxygenase-2 (COX-2), celecoxib and parecoxib: a systematic review]. Mateos JL Drugs Today (Barc); 2010 Feb; 46 Suppl A():1-25. PubMed ID: 20224826 [TBL] [Abstract][Full Text] [Related]
3. Clinical pharmacology of celecoxib, a COX-2 selective inhibitor. Antoniou K; Malamas M; Drosos AA Expert Opin Pharmacother; 2007 Aug; 8(11):1719-32. PubMed ID: 17685888 [TBL] [Abstract][Full Text] [Related]
4. [Clinical pharmacology of the selective COX-2 inhibitors]. Burian M; Geisslinger G Orthopade; 2003 Dec; 32(12):1078-87. PubMed ID: 14655004 [TBL] [Abstract][Full Text] [Related]
5. A systematic review of COX-2 inhibitors compared with traditional NSAIDs, or different COX-2 inhibitors for post-operative pain. Rømsing J; Møiniche S Acta Anaesthesiol Scand; 2004 May; 48(5):525-46. PubMed ID: 15101847 [TBL] [Abstract][Full Text] [Related]
6. Role of cyclooxygenase-2 inhibitors in postoperative pain management. Gajraj NM; Joshi GP Anesthesiol Clin North Am; 2005 Mar; 23(1):49-72. PubMed ID: 15763411 [TBL] [Abstract][Full Text] [Related]
7. How specific are "target-specific" drugs? Celecoxib as a case in point. Sadée W; Bohn L Mol Interv; 2006 Aug; 6(4):196-8. PubMed ID: 16960141 [TBL] [Abstract][Full Text] [Related]
8. A parallel-group comparison study of celecoxib with loxoprofen sodium in third mandibular molar extraction patients. Yamashita Y; Sano N; Shimohira D; Danjo A; Goto M Int J Oral Maxillofac Surg; 2014 Dec; 43(12):1509-13. PubMed ID: 25270186 [TBL] [Abstract][Full Text] [Related]
9. Fixed drug eruption caused by etoricoxib with tolerance to celecoxib and parecoxib. Ponce V; Muñoz-Bellido F; Moreno E; Laffond E; González A; Dávila I Contact Dermatitis; 2012 Feb; 66(2):107-8. PubMed ID: 22233472 [No Abstract] [Full Text] [Related]
10. Efficacy and safety of Postoperative Intravenous Parecoxib sodium Followed by ORal CElecoxib (PIPFORCE) post-total knee arthroplasty in patients with osteoarthritis: a study protocol for a multicentre, double-blind, parallel-group trial. Zhuang Q; Bian Y; Wang W; Jiang J; Feng B; Sun T; Lin J; Zhang M; Yan S; Shen B; Pei F; Weng X BMJ Open; 2016 Sep; 6(9):e011732. PubMed ID: 27609846 [TBL] [Abstract][Full Text] [Related]
11. Celecoxib: a review of its use in the management of arthritis and acute pain. Frampton JE; Keating GM Drugs; 2007; 67(16):2433-72. PubMed ID: 17983259 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of additional 200-mg dose of celecoxib in adult patients with postoperative pain following extraction of impacted third mandibular molar: a multicenter, randomized, double-blind, placebo-controlled, phase II study in Japan. Saito K; Kaneko A; Machii K; Ohta H; Ohkura M; Suzuki M Clin Ther; 2012 Feb; 34(2):314-28. PubMed ID: 22284900 [TBL] [Abstract][Full Text] [Related]
13. Celecoxib: considerations regarding its potential disease-modifying properties in osteoarthritis. Zweers MC; de Boer TN; van Roon J; Bijlsma JW; Lafeber FP; Mastbergen SC Arthritis Res Ther; 2011; 13(5):239. PubMed ID: 21955617 [TBL] [Abstract][Full Text] [Related]
14. The efficacy of oral celecoxib for acute postoperative pain in face-lift surgery. Aynehchi BB; Cerrati EW; Rosenberg DB JAMA Facial Plast Surg; 2014; 16(5):306-9. PubMed ID: 25010711 [TBL] [Abstract][Full Text] [Related]
15. Preoperative use of selective COX-II inhibitors for pain management in laparoscopic nissen fundoplication. Alanoglu Z; Ateş Y; Orbey BC; Türkçapar AG Surg Endosc; 2005 Sep; 19(9):1182-7. PubMed ID: 16132321 [TBL] [Abstract][Full Text] [Related]
16. The burden of acute postoperative pain and the potential role of the COX-2-specific inhibitors. Stephens J; Laskin B; Pashos C; Peña B; Wong J Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii40-52. PubMed ID: 14585917 [TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase-2 specificity and its clinical implications. Lefkowith JB Am J Med; 1999 May; 106(5B):43S-50S. PubMed ID: 10390127 [TBL] [Abstract][Full Text] [Related]
19. COX-2 selective inhibitors in the treatment of arthritis: a rheumatologist perspective. Hochberg MC Curr Top Med Chem; 2005; 5(5):443-8. PubMed ID: 15974939 [TBL] [Abstract][Full Text] [Related]
20. [EFFICACY OF SEQUENTIAL TREATMENT WITH ADDUCTOR CANAL NERVE BLOCK AND CYCLOOXYGENASE 2 SELECTIVE INHIBITOR AFTER TOTAL KNEE ARTHROPLASTY]. Yang T; Si H; Wu Y; Zeng Y; Pei F; Weng X; Shen B Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2016 Sep; 30(9):1065-1071. PubMed ID: 29786356 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]